Scenarios that move GPCR
Structure Therapeutics Inc. - American Depositary Shares
Scenarios that move GPCR: 8 analyses, 4 positive, 4 negative.
- · Viking Therapeutics advances oral obesity drug to Phase III — ▲ · impact +52 · confidence high · horizon immediate
- · Zealand Pharma reports positive survodutide Phase III weight loss results — ▲ · impact +35 · confidence low · horizon immediate
- · Novo Nordisk's Ozempic outperforms Lilly's Mounjaro on cardiovascular risk — ▼ · impact -42 · confidence low · horizon quarters
- · Novo and Hengrui sign exclusive license for oral GLP-1/GIP drug — ▼ · impact -50 · confidence medium · horizon immediate
- · Pharma stock soars 150% after injectables deal with Novo — ▼ · impact -26 · confidence medium · horizon weeks
- · ◇ What if… Oral GLP-1 drugs replace injectable treatments — ▲ · impact +80 · confidence high · horizon quarters
- · Viking Therapeutics stock skyrockets in Tuesday trading — ▲ · impact +52 · confidence high · horizon immediate
- · Eli Lilly Weight Loss Pill Shows Better Results Than Injectable Competitors In Phase 3 Trial — ▼ · confidence low